annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the launch of PSMA PET/CT[1] Today, a five-part video series, featuring leading theranostics experts, on the role of advanced diagnostic imaging in prostate cancer care. (PRNewsfoto/Telix Pharmaceuticals Limited)
Hosted by Dr. Neal Shore, Chief Medical Officer of Surgical Oncology and Urology with GenesisCare and director at Carolina Urologic Researc...
>>> Read more: New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts
Hosted by Dr. Neal Shore, Chief Medical Officer of Surgical Oncology and Urology with GenesisCare and director at Carolina Urologic Researc...
>>> Read more: New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts
